靶向人CPNE7可变剪接异构体的鼠源抗血清制备与应用鉴定OA
Preparation and characterization of mouse antiserum targeting human CPNE7 alternative splice isoforms
目的 钙依赖性膜结合蛋白7(CPNE7)的关键可变剪接异构体在多种肿瘤中异常表达,为深入研究其功能,本研究拟制备一种能特异性同时识别CPNE7-FL与CPNE7-S两种主要可变剪接异构体的鼠源抗血清.方法 基于生物信息学筛选CPNE7异构体的共同保守序列,设计并合成肽段免疫8只BALB/c小鼠制备抗血清,通过间接ELISA测定抗血清效价.随后,构建CPNE7原核表达载体并建立A549细胞过表达体系,采用Western blot验证抗血清的特异性.结果 成功获得效价达1∶320 00的抗血清.Western blot结果表明,该抗血清能有效识别原核表达的GST-CPNE7融合蛋白,并能在真核细胞中检测到过表达的CPNE7-FL与CPNE7-S异构体.结论 本研究成功制备了高效价、高特异性的抗人CPNE7抗血清,为后续开展CPNE7异构体表达谱分析、功能研究及其在肿瘤诊疗中的作用提供有效的研究工具.
Objective Aberrant expression of key alternative splice isoforms of calcium-dependent membrane-binding protein 7(CPNE7)has been observed in various cancers.To facilitate functional studies,this study aims to generate a mouse-derived antiserum capable of specifically recognizing both major splice variants,CPNE7-FL and CPNE7-S.Methods Conserved sequences shared among CPNE7 isoforms were identified by bioinformatic a-nalysis,and synthetic peptides were designed and used to immunize eight BALB/c mice to prepare antiserum.The antiserum titer was determined by indirect ELISA.Subsequently,a prokaryotic expression vector for CPNE7 was constructed and an A549 overexpression system was established,and the specificity of the antiserum was ver-ified by Western blot.Results A high-titer antiserum with a dilution of up to 1∶32 000 was successfully ob-tained.Western blot results showed that the antiserum effectively recognized recombinant GST-CPNE7 fusion proteins in E.coli and detected the overexpressed CPNE7-FL and CPNE7-S isoforms in mammalian cells.Conclusion A high-titer and high-specificity mouse antiserum against human CPNE7 was successfully prepared.This antiserum provides a valuable tool for future studies on the expression patterns and biological functions of CPNE7 isoforms,laying a foundation for exploring their potential roles in cancer diagnosis and therapy.
王彬睿;马中琪;常峥;李艳萍;周欢思;金明静;赵黎梅;颜健华;卢春花
广西中医药大学附属国际壮医医院壮瑶医药研究实验室,广西南宁 530200广西大学医学院,广西南宁 530004南宁市第一人民医院医学实验中心,广西南宁 530021广西中医药大学附属国际壮医医院壮瑶医药研究实验室,广西南宁 530200广西中医药大学附属国际壮医医院壮瑶医药研究实验室,广西南宁 530200广西中医药大学附属国际壮医医院壮瑶医药研究实验室,广西南宁 530200南宁市第一人民医院医学实验中心,广西南宁 530021广西大学医学院,广西南宁 530004广西中医药大学附属国际壮医医院壮瑶医药研究实验室,广西南宁 530200||南宁市第一人民医院医学实验中心,广西南宁 530021
医药卫生
钙依赖性膜结合蛋白7可变剪接抗血清抗体制备
calcium-dependent membrane-binding protein 7alternative splicingantiserumantibody pro-duction
《遵义医科大学学报》 2026 (6)
596-604,9
广西自然科学基金重点项目(NO:2018GXNSFDA050009).
评论